Introduction: The National Institute of Health (NIH) registry for primary pulmonary hypertension (PPH) established prognostic factors for PPH (now WHO group 1 PH). Diastolic pulmonary gradient {(DPG), Pulmonary artery diastolic pressure-mean Pulmonary capillary wedge pressure} ≥ 7 mmHg is associated with pulmonary vascular disease and a poor prognosis in heart failure (HF). The prognostic relevance of DPG in group 1 PH is uncertain. Methods: Using the NIH risk stratification equation for 239 patients in the NIH-PPH registry, the 5-year probability of death was calculated. The NIH model was then compared with DPG using a Cox proportional hazards model. Kaplan-Meier survival curves were determined for two cohorts using the median DPG of 30 mmHg as cutoff, and significance was tested using the logrank test. Results: The median age of patients was 38.1 ± 16.0 years old, 63% were female, and 72% had race reported as “white”. The mean DPG was 31.5 mmHg (± 13.6 mm Hg) and only 17.4% of patients had a DPG < 7 mm Hg. In a Cox proportional hazards model, increasing DPG was significantly associated with 5-year mortality even after adjustment for the NIH risk equation (DPG HR 1.18 per 10 mm Hg increase [95% CI 1.05-1.32]), and the chi square statistic for DPG compared favorably with the NIH risk equation (15.6 versus 26.2). When DPG was dichotomized based on the median value of 30 mm Hg, the hazard ratio for DPG > 30 mm Hg with respect to 5-year mortality was 1.91, 95% CI [1.34-2.75] (Figure). In a separate Cox model adjusted for pulmonary artery systolic pressure (PASP), increasing DPG remained significantly associated with decreased survival over 5 years (HR 1.45 for DPG > 30 mm Hg, 95% CI [1.01, 2.10]). Conclusions: DPG has higher distribution in PH than previously reported in HF studies and is associated with survival in group 1 PH patients even after adjustment for the NIH risk equation or PASP. More studies are needed to evaluate the use of DPG in guiding treatment and prognosis in group 1 PH.